Literature DB >> 4911257

Oral L-dopa treatment of parkinsonism.

N E Andén, A Carlsson, J Kerstell, T Magnusson, R Olsson, B E Roos, B Steen, G Steg, A Svanborg, G Thieme, B Werdinius.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4911257     DOI： 10.1111/j.0954-6820.1970.tb02939.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN： 0001-6101


× No keyword cloud information.
  18 in total

1.  Letter: Mental changes in Parkinsonism.

Authors:  J Pearce
Journal:  Br Med J       Date:  1974-05-25

Review 2.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

3.  On the relationship between L-DOPA therapy and CSF monoamine metabolites in Parkinson's disease.

Authors:  C Casati; A Agnoli; A Jori; E Dolfini
Journal:  Z Neurol       Date:  1973-04-02

4.  L-dopa level in plasma, primary condition for the kinetic effect.

Authors:  W Birkmayer; W Danielcyk; E Neumayer; P Riederer
Journal:  J Neural Transm       Date:  1973       Impact factor: 3.575

5.  Editorial: Mental changes in Parkinsonism.

Authors: 
Journal:  Br Med J       Date:  1974-04-06

6.  Relationship of age and mood to monoamine metabolites in cerebrospinal fluid in parkinsonism.

Authors:  A K Granerus; T Magnusson; B E Roos; A Svanborg
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

7.  5-Hydroxyindoleacetic acid in cerebrospinal fluid of patients with Parkinson's syndrome treated with L dopa.

Authors:  B Johansson; B E Roos
Journal:  Eur J Clin Pharmacol       Date:  1971-09       Impact factor: 2.953

Review 8.  Assessment of extrapyramidal disorders.

Authors:  C D Marsden; M Schachter
Journal:  Br J Clin Pharmacol       Date:  1981-02       Impact factor: 4.335

9.  Measurement and kinetic study of the formation of adrenaline sulphate in vitro.

Authors:  K P Wong
Journal:  Biochem J       Date:  1978-09-15       Impact factor: 3.857

10.  Selective loss of bi-directional synaptic plasticity in the direct and indirect striatal output pathways accompanies generation of parkinsonism and l-DOPA induced dyskinesia in mouse models.

Authors:  Sherri L Thiele; Betty Chen; Charlotte Lo; Tracey S Gertler; Ruth Warre; James D Surmeier; Jonathan M Brotchie; Joanne E Nash
Journal:  Neurobiol Dis       Date:  2014-08-27       Impact factor: 5.996
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.